Helendale Dermatology, Rochester, NY Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00441415
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Helendale Dermatology - Rochester NY - 585-266-5420

Active Ingredients

Drugs in Phase 3 Trials (1)

adapalene (differin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1